GlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis Treatment

Stock Information for Noble Roman`s, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Noble Roman`s, Inc.

Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials
Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare to Manage Clinical Trial, Regulatory Filings, Manufacturing and Sales in MEA Region for Multiple Sclerosis Treatment
Presenting on the Emerging Growth Conference on July 12 & 13 Register Now
Globestar Therapeutics Enters into MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
GlobeStar Therapeutics Corporation Update on Recent Activity
CEOs Presenting at the Emerging Growth Conference on April 27; Register Now
CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract
GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.